Ugandan health experts are advising individuals who have received the first dose of the HIV prevention injection, Lenacapavir, to continue utilizing combination prevention methods. Despite the drug's promising impact and high demand, officials emphasize it is *not* a vaccine and doesn't guarantee complete immunity. The twice-yearly injection is a significant advancement, but relying on it as a sole preventative measure is cautioned against. Experts recommend layering Lenacapavir with other strategies like safe sex practices and PrEP. This combined approach is crucial for maximizing protection against HIV infection. Further guidance is expected as more data becomes available regarding the long-term efficacy of Lenacapavir. The intention is to ensure recipients maintain comprehensive HIV prevention plans.